Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-001727-19-IT
EUCTR2006-001727-19-IT
Active, not recruiting
Not Applicable

Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy - ND

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 sitesDecember 4, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsexudative maculopathyMedDRA version: 8.1Level: LLTClassification code 10038862Term: Retinal exudates
DrugsKENACORT*3FL 1ML 40MG/ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
exudative maculopathy
Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 4, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Eligibility Criteria

Inclusion Criteria

  • •Age 18 years Male and Female patients affected by secondary macular oedema due to retinal central vein occlusion, by macular oedema due to diabetes, uveitis, coroidal neovascularization connected with AMD, vitreo\-retinal proliferation, by macular oedema consequent to phacoemulsification, to neovascular glaucoma, to telangiectasia, by macular oedema connected with retinitis pigmentosa or with age\-related maculopathy.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Women who are pregnant or breastfeeding Clinical history of chronic ocular incfections Clinical history of Glaucoma

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Intravitreal Injection of Triamcinolone Acetonide in Retinitis
IRCT201104266293N1Tehran University of Medical Sciences161
Completed
Phase 4
The Use of Intravitreal Injection of Triamcinolone Acetonide in Diabetic Patients to Reduce Diabetic Macular EdemaDiabetic macular edemaEye - Diseases / disorders of the eye
ACTRN12613000249752suez canal university hospital19
Completed
Phase 2
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)Diabetic Macular OedemaMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eye
ACTRN12605000211662Professor Mark Gillies70
Completed
Not Applicable
Intravitreal triamcinolone acetonide combined withccataract surgery for diabetic macular edemadiabetic macular edema
JPRN-UMIN000029818Department of Ophthalmology, Mie University Graduate School of Medicine30
Completed
Not Applicable
Intravitreal Triamcinolone with Transpupillary Thermal Therapy (TTT) for Subfoveal Choroidal Neovascularization in Age Related Macular DegeneratioAge-Related Macular Degeneration (ARMD) not available for current therapiesEye DiseasesAge-Related Macular Degeneration (ARMD)
ISRCTN74123635Association to Avoid Blindness (Asociación Para Evitar La Ceguera) (APEC) (Mexico)200